4-(1-(sulfonyl)-1H-indol-2-yl)-4-(hydroxy )-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents

Details for Australian Patent Application No. 2002353193 (hide)

Owner Cancer Research Technology Limited

Inventors Berry, Jane Marie; Stevens, Malcolm Francis Graham; Poole, Tracey Dawn; Westwell, Andrew David; Wells, Geoffrey

Agent FB Rice

Pub. Number AU-B-2002353193

PCT Number PCT/GB02/05842

PCT Pub. Number WO2004/056361

Filing date 20 December 2002

Wipo publication date 14 July 2004

Acceptance publication date 25 March 2010

International Classifications

A61K 31/404 (2006.01)

C07D 209/12 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

20 March 2003 Complete Application Filed

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2002353193

25 March 2010 Application Accepted

  Published as AU-B-2002353193

22 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002353194-Call processing in mobile telecommunications networks

2002353192-PARTICULATE METAL OXIDE